Delivery Order SPE2DB24D2205-SPE2DB24FDWBR
Award Date
6/26/24
Potential Completion Date
7/18/24
Potential Value
$9.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $3,756.72, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office...
The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $8,996.48, is for the supply of HYPERRAB 300 UNIT/ML VIAL 3ML, a medical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical facilities. The $11,270.10 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a for-profit organization and a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The award is part of an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, valued at up...
This federal contract award is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract has a ceiling value of $18,783.50 and is a Delivery Order under a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $14,326.40 and a completion date of May 8, 2025. The contract is not set aside and involves the procurement of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,495.36 firm fixed-price delivery order is for the supply of 4,558,026,689 units of HYPERRAB 300 UNIT/ML VIAL 5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 29, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of HYPERRAB 300 UNIT/ML VIAL 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $7,871.92 and was awarded on a Firm Fixed Price basis. It is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This federal contract award, with a total ceiling value of $7,513.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,490.29 firm fixed-price delivery order is for the supply of HYPERRAB 300 UNIT/ML VIAL 3ML medical products. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.12 Firm Fixed Price Delivery Order covers the supply of HYPERRAB 300 UNIT/ML VIALML, a pharmaceutical product, with a period of performance through January 22, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...